Veraxa Biotech AG - Post de-SPAC reported asset growth of 4.50% for the quarter ended Dec 2025. These growth metrics cover 1 quarter of results, standardized by Business Quant from the company’s SEC filings.
| Growth Metrics | Dec2025 |
|---|---|
| Growth Ratios | |
| Assets Growth (1y) | 4.50% |
| Cash & Equivalents Growth (1y)Cash & Equiv. Growth (1y) | -67.01% |
| Property, Plant & Equipment (Net) Growth (1y)PP&E (Net) Growth (1y) | 10.90% |
Pull Veraxa Biotech AG - Post de-SPAC's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/statements?ticker=VRXA&statement=Growth&frequency=Quarter&period=all&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/statements"
params = {"ticker": "VRXA", "statement": "Growth", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/statements?ticker=VRXA&statement=Growth&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();